Lung Cancer, Dana-Farber Cancer Institute Handbook

Lung Cancer

Dana-Farber Cancer Institute Handbook

Edited by Arthur T. Skarin, MD, FACP, FCCP, Associate Professor of Medicine, Harvard Medical School, Boston, MA, USA; Senior Attending Physician, Dana-Farber Cancer Institute, Boston, MA, USA; and Paul Lorigan, MB, FRCP, Senior Lecturer in Medical Oncology, Christie Hospital NHS Trust, Manchester, UK


Introduction

The role of molecular probes and other markers in the diagnosis and characterization of malignancy

Lung cancer: aetiology, histopathology and clinical manifestation

Lung cancer treatment

Systemic and mucocutaneous reactions to chemotherapy